查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827667

2025年全球体外诊断市场报告

In Vitro Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体外诊断市场快速扩张，市场规模将从2024年的1,219.6亿美元成长至2025年的1,365.5亿美元，复合年增长率达12.0%。预测期内的成长主要受自动化分析仪和分子诊断技术的发展、人口老化、疾病爆发、医疗法规以及个人化医疗等因素的推动。

预计未来几年体外诊断市场将快速成长，到2029年将达到2,148.8亿美元，复合年增长率为12.0%。预测期内的成长可归因于精准医疗、就地检验、数位健康和​​数据分析以及疫情预防措施。预测期内的主要趋势包括技术进步、数位健康整合、个人化诊断、家用检测套组和分子诊断。

体外诊断 (IVD) 是指对从人体采集的生物样本（例如血液、组织或尿液）进行的检测，用于识别疾病、病症和感染疾病。这些检测在受控环境（例如实验室）中使用专门的设备和试剂在体外进行。 IVD 在诊断各种健康状况、确定治疗方案以及长期监测患者健康状况方面发挥着重要作用。

体外诊断的主要类别包括照护现场诊断仪器和设备、免疫化学诊断仪器和设备、临床化学诊断仪器和设备、分子诊断仪器和设备、微生物学诊断仪器和设备、止血诊断仪器和设备、血液学诊断仪器和设备以及免疫血液学诊断仪器和设备。例如，血液学仪器是用于分析血液样本、测量血球计数、检测蛋白质和酵素以及辅助诊断疾病和基因缺陷的机器。这些仪器和设备在公共和私人场所都有使用，不仅包括仪器和设备，还包括耗材。这些设备的最终用户包括医院、诊所、诊断实验室和其他相关机构。

2025年春季美国关税突然上调及其引发的贸易摩擦，对医疗设备领域产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供了体外诊断医疗器材市场的统计数据，包括全球市场规模、各地区市场份额、各竞争对手的市场份额、体外诊断医疗器材市场的细分市场、市场趋势和机会，以及在体外诊断医疗器材行业取得成功所需的数据。这份体外诊断医疗设备市场研究报告提供了所有必要资讯的完整展望，并对产业现状和未来情势进行了详细分析。

我们对该市场未来五年12.0%的成长率预测与先前的预测保持一致。造成这一下降的主要原因是美国与其他国家之间关税的影响。这可能会透过对来自台湾和荷兰等关键地区的微流体晶片和高灵敏度生物感测器征收关税直接影响美国，从而导致检测能力下降和临床实验室营运成本上升。此外，由于贸易紧张局势加剧和限制措施加剧，互惠关税以及对全球经济和贸易的负面影响也将更广泛地显现。

预计未来几年，自助检测套组的普及将推动体外诊断市场的扩张。这些检测套组专为自助使用而设计，无需医疗专业人员或受过培训的人员进行检测，人们可以在家中进行诊断评估。这种可近性和便利性的提高可能会增加对检测的需求，尤其是对那些以前可能未被发现的疾病的检测需求。例如，美国疾病管制与预防中心 2022 年 4 月的统计数据显示，在美国18 岁及以上的成年人中，使用家庭 COVID-19 检测的人数显着增加。将Delta占主导地位的时期（2021 年 8 月至 12 月）与 Omicron 占主导地位的时期（2022 年 12 月至 3 月）进行比较，在出现 COVID-19 样症状的受访者中，使用家庭检测的比例显着增加，从 5.7% 上升到 20.1%。因此，自我管理检测套组的日益普及预计将推动体外诊断市场的成长。

预计癌症盛行率的上升将推动体外诊断市场的发展。癌症涵盖多种疾病，在身体各部位有 100 多种表现，其特征是细胞不受控制地生长和扩散。体外诊断 (IVD) 包括分析从人体采集的样本的测试和医疗设备，以提供癌症筛检、诊断和治疗所必需的资讯。例如，美国政府间组织国家生物技术资讯中心在 2023 年 1 月预测，2023 年美国新增癌症病例数和癌症相关死亡人数将分别达到 1,958,310 例和 609,820 例。因此，癌症发生率的预期成长将推动体外诊断市场的成长。

体外诊断市场的主要企业正专注于开发创新产品，例如 Cobas 脉搏系统，这是一种专门的血糖管理解决方案，具有行动数位健康功能，可增强患者照护。例如，2022 年 1 月，罗氏诊断公司（Roche Diagnostics）推出了 Cobas 脉搏系统，这是一家专门从事疾病预防、诊断、监测、筛检和治疗创新产品和服务的美国公司。这款携带式设备由自动血糖试纸读取器、相机和用于捕获其他诊断数据的触控萤幕组成。使用者友善的介面旨在实现无缝集成，并包含优化流程、节省时间和改进操作工作流程的便利功能。

体外诊断 (IVD) 市场的主要企业正在整合先进技术，例如 UIMG 成像技术和二维解码晶片，以提高诊断准确性和效率，改进数据分析，优化工作流程，并最终改善患者预后。 UIMG 成像技术是一种用于诊断的先进成像技术，用于捕捉和分析高解析度影像，从而增强生物样本的可视化和解读能力。例如，2023 年 11 月，总部位于荷兰、服务于欧洲、中东和非洲的科技公司 Neuland 推出了新的 IVD 产品线。该产品线包含五种紧凑耐用的条码扫描器，旨在优化自动化诊断流程，满足日益增长的高效医疗保健解决方案需求，并提高诊断速度和准确性。

体外诊断市场的主要企业包括西门子医疗公司、罗氏公司、丹纳赫集团、雅培实验室公司、赛默飞世尔科技公司、安捷伦科技公司、美利坚合众国公司、Arkray公司、碧迪公司、Bio-Rad实验室公司、bioMerieux SA、Grifols SA、Hologic公司、Werfen。 SA、Laboratory Corporation、Luminex Corporation、Ortho Clinical Diagnostics、PerkinElmer Inc.、Qiagen NV、Quest Diagnostics Inc.、QuidelOrtho Corporation、Sysmex Corporation、Illumina Inc.、Menarini Silicon Biosystems SPA、SpeeDx Pty.Ltd.、GGEEDAV​​Ax 或Ak 或k 或kOR、F错误. Sciences Inc.、Bio-Techne Corporation、Myriad Genetics Inc.、Genomic Health Inc.、Exact Sciences Crop.、Natera Inc.、Invitae Crop. 和 Veracyte Inc.

2024年，北美是全球体外诊断市场最大的地区。亚太地区是全球体外诊断市场的第二大地区。体外诊断设备和器械市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

IVD市场报告涵盖澳洲、中国、印度、印尼、日本、韩国、孟加拉、泰国、越南、马来西亚、新加坡、菲律宾、香港、纽西兰、美国、加拿大、墨西哥、巴西、智利、阿根廷、哥伦比亚、秘鲁、法国、德国、英国、奥地利、比利时、丹麦、芬兰、爱尔兰、义大利、荷兰、英国、葡萄牙、西班牙、瑞典、瑞士、俄罗斯、捷克共和国、波兰联合国、美国、欧洲、伊朗、伊朗、俄罗斯、伊朗、俄罗斯、俄罗斯和伊朗、民族、伊朗、伊朗、埃及、伊朗、俄罗斯和伊朗、伊朗、俄罗斯和伊朗、伊朗、伊朗、俄罗斯和伊朗、伊朗、伊朗、俄罗斯和伊朗、民族、伊朗、欧洲、伊朗、伊朗、俄罗斯、伊朗、伊朗、俄罗斯和伊朗、民族、伊朗、欧洲、伊朗、伊朗、俄罗斯、伊朗、伊朗、欧洲、伊朗、伊朗、民族、伊朗、欧洲、伊朗、伊朗、伊朗、伊朗、伊朗、俄罗斯、欧洲、伊朗、欧洲、伊朗、伊朗、欧洲、伊朗、欧洲、伊朗、」伊朗、欧洲、美国、伊朗、欧洲、伊朗、伊朗、欧洲、伊朗、伊朗、俄罗斯、美国、伊朗、欧洲、美国、伊朗、欧洲、伊朗、」

体外诊断市场包括套件、试剂、软体、系统和仪器的销售。该市场的价值是指“出厂价”，即商品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球体外诊断：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球体外诊断市场：增长率分析
  • 全球体外诊断市场表现：规模与成长，2019-2024
  • 全球体外诊断市场预测：规模与成长，2024-2029年，2034年
  • 全球体外诊断：总目标市场（TAM）

第六章 市场细分

  • 全球体外诊断市场类型、绩效及预测（2019-2024、2024-2029、2034）
  • 照护现场诊断设备和仪器
  • 免疫化学诊断仪器设备
  • 临床化学诊断设备与仪器
  • 分子诊断设备与仪器
  • 微生物诊断设备与仪器
  • 血液凝固诊断仪器及设备
  • 血液诊断设备
  • 免疫血液学诊断设备及仪器
  • 全球体外诊断市场支出类型、实际及预测（2019-2024、2024-2029、2034）
  • 公共
  • 私人的
  • 全球体外诊断市场用途、表现及预测（2019-2024、2024-2029、2034）
  • 用具/设备
  • 一次性的
  • 全球体外诊断市场最终用户、绩效及预测（2019-2024、2024-2029、2034）
  • 医院和诊所
  • 诊断实验室
  • 其他的
  • 全球体外诊断市场：照护现场诊断设备和仪器细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 血糖监测
  • 妊娠和生育能力测试
  • 传染病检查
  • 心臟标记检测
  • 血液凝固检验
  • 全球体外诊断市场：免疫化学诊断仪器和设备细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 酵素免疫分析法（ELISA）
  • 免疫检测（RIA）
  • 蛋白质印迹法
  • 萤光试验
  • 化学冷光免疫检测（CLIA）
  • 全球体外诊断市场：临床化学诊断仪器和设备细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 血糖值检测
  • 胆固醇检测
  • 肝功能检查
  • 肾功能检查
  • 电解质测试
  • 全球体外诊断市场：分子诊断设备和仪器细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • PCR（聚合酵素链锁反应）设备
  • 下一代定序（NGS）设备
  • 微阵列设备
  • FISH（萤光原位杂合反应）设备
  • 全球体外诊断市场：微生物诊断仪器和设备细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 微生物培养系统
  • 自动辨识系统
  • 抗菌药物敏感性测试系统
  • 血液培养系统
  • 全球体外诊断市场：止血诊断仪器和设备细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 凝血分析仪
  • 血栓弹力图系统
  • 血小板功能分析仪
  • 凝血因子分析仪
  • 全球体外诊断市场：血液学诊断仪器和设备细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 血液分析仪
  • 血红素检测系统
  • 全血细胞计数（CBC）仪
  • 血球计数器
  • 全球体外诊断市场：免疫血液学诊断设备和设备细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 血型系统
  • 交叉配对检查系统
  • 抗体筛检系统
  • 血库分析仪

第七章 区域和国家分析

  • 全球体外诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球体外诊断市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 孟加拉市场

第十六章 泰国市场

第十七章 越南市场

第十八章 马来西亚市场

第十九章：新加坡市场

第二十章：菲律宾市场

第21章 香港市场

第22章：纽西兰市场

第23章 西欧市场

第24章英国市场

第25章：德国市场

第26章：法国市场

第27章：义大利市场

第28章：西班牙市场

第29章：西班牙市场

第30章：奥地利市场

第31章：比利时市场

第32章：丹麦市场

第33章 芬兰市场

第34章：爱尔兰市场

第35章：荷兰市场

第36章：挪威市场

第37章：葡萄牙市场

第38章：瑞典市场

第39章：瑞士市场

第41章俄罗斯市场

第42章 捷克共和国市场

第43章：波兰市场

第44章：罗马尼亚市场

第45章：乌克兰市场

第46章 北美市场

第47章美国市场

第48章：加拿大市场

第50章：南美市场

第51章：巴西市场

第52章 智利市场

第53章：阿根廷市场

第54章：哥伦比亚市场

第55章秘鲁市场

第56章 中东市场

第57章：沙乌地阿拉伯市场

第58章：以色列市场

第59章 伊朗市场

第60章 土耳其市场

第61章：阿拉伯联合大公国市场

第62章 非洲市场

第63章埃及市场

第64章 尼日利亚市场

第65章南非市场

第66章：竞争格局与公司概况

  • 体外诊断市场：竞争格局
  • 体外诊断市场：公司简介
    • Siemens Healthineers
    • F. Hoffmann-La Roche AG
    • Danaher Corporation
    • Abbott Laboratories Inc.
    • Thermo Fisher Scientific Inc.

第 67 章：其他领先和创新企业

  • Agilent Technologies Inc.
  • Alere Inc.
  • Arkray Inc.
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Grifols SA
  • Hologic Inc.
  • Werfen SA
  • Laboratory Corporation
  • Luminex Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer Inc.
  • Qiagen NV
  • Quest Diagnostics Inc.

第 68 章：全球市场竞争基准化分析与仪錶板

第69章：重大併购

第70章近期市场趋势

第71章：市场潜力大的国家与策略

  • 2029年体外诊断市场：提供新机会的国家
  • 2029年体外诊断市场：细分领域带来新机会
  • 2029年体外诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第72章 附录

简介目录
Product Code: r32599u

In vitro diagnostics (IVD) are tests performed on biological samples, such as blood, tissue, or urine, collected from the human body to identify diseases, conditions, or infections. Conducted outside the body in controlled environments like laboratories, these tests utilize specialized equipment and reagents. IVDs play a vital role in diagnosing various health conditions, guiding treatment decisions, and monitoring patient health over time.

The principal categories of in-vitro diagnostics equipment encompass point-of-care diagnostics devices and equipment, immunochemistry diagnostic devices and equipment, clinical chemistry diagnostics devices and equipment, molecular diagnostics devices and equipment, microbiology diagnostic devices and equipment, hemostasis diagnostic devices and equipment, hematology diagnostic devices and equipment, and immunohematology diagnostic devices and equipment. Hematology instruments, for instance, are machines designed to analyze blood samples, perform blood counts, detect proteins or enzymes, and aid in the diagnosis of diseases or genetic defects. These devices and equipment are used in both public and private settings and involve instruments/equipment as well as disposables. The end-users for these tools include hospitals and clinics, diagnostic laboratories, and other relevant institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The in-vitro diagnostics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics devices and equipment market statistics, including in-vitro diagnostics devices and equipment industry global market size, regional shares, competitors with an in-vitro diagnostics devices and equipment market share, detailed in-vitro diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics devices and equipment industry. This in-vitro diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro diagnostics market size has grown rapidly in recent years. It will grow from $121.96 billion in 2024 to $136.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to the development of automated analyzers and molecular diagnostics, aging population, disease outbreaks, healthcare regulations, personalized medicine.

The in vitro diagnostics market size is expected to see rapid growth in the next few years. It will grow to $214.88 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to precision medicine, point-of-care testing, digital health and data analytics, pandemic preparedness. Major trends in the forecast period include technological advancements, digital health integration, personalized diagnostics, home testing kits, molecular diagnostics.

The forecast of 12.0% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microfluidic chips and high-sensitivity biosensors, sourced from key regions such as Taiwan and the Netherlands, which could lead to reduced testing capacity and increased costs for clinical laboratory operations.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing adoption of self-administered test kits is set to fuel the expansion of the in vitro diagnostics market in the forthcoming years. These kits are designed for self-use, eliminating the necessity for medical professionals or trained individuals to conduct the tests, allowing people to perform diagnostic evaluations at their residences. This increased accessibility and convenience could potentially result in a higher demand for testing, especially for conditions that may have previously gone undetected. For example, statistics from the Centers for Disease Control and Prevention in April 2022 exhibited a significant surge in the use of at-home COVID-19 tests among adults aged 18 and older in the United States. Comparing the Delta-dominant period (August to December 2021) to the Omicron-dominant period (December to March 2022), there was a notable increase in at-home test utilization among respondents experiencing symptoms resembling COVID-19, rising from 5.7% to 20.1%. Hence, the increasing adoption of self-administered test kits is anticipated to be a driving factor in the growth of the in vitro diagnostics market.

The projected rise in the prevalence of cancer is expected to drive the expansion of the in vitro diagnostics market. Cancer comprises a wide array of over 100 diseases that can manifest in various parts of the body, characterized by the uncontrolled proliferation and dissemination of cells. In vitro diagnostics (IVDs) encompass tests or medical devices that analyze samples obtained from the human body, providing vital information for the screening, diagnosis, and treatment of cancer. For instance, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, projected that there would be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States for the year 2023. Consequently, the anticipated rise in cancer prevalence is set to drive the growth of the in vitro diagnostics market.

Key companies in the in vitro diagnostics market are focusing on the development of innovative products to drive their market growth, such as the Cobas pulse system. This system is a professional blood glucose management solution equipped with mobile digital health capabilities to enhance patient care. For example, in January 2022, Roche Diagnostics, a US-based company specializing in innovative products and services addressing disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system. This portable device comprises an automated glucose test strip reader, a camera, and a touchscreen for capturing additional diagnostic data. Its user-friendly interface is designed for seamless integration, providing convenient functionalities that optimize processes, save time, and improve operational workflows.

Major players in the in vitro diagnostics (IVD) market are incorporating advanced technologies, such as UIMG image technology and 2D decoder chips, to enhance diagnostic accuracy and efficiency, improve data analysis, optimize workflows, and ultimately deliver better patient outcomes. UIMG image technology is an advanced imaging technique used in diagnostics to capture and analyze high-resolution images, enhancing the visualization and interpretation of biological samples. For example, in November 2023, Newland, a Netherlands-based technology company in the EMEA region, launched a new IVD product line. This product line includes five barcode scanners that are compact, durable, and designed to optimize automated diagnostic processes, aiming to boost diagnostic speed and accuracy in response to the growing demand for efficient healthcare solutions.

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMerieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the in vitro diagnostics market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The in-vitro diagnostics devices and equipment market consist of sales of kits, reagents, piece of software, system, and instrument. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Point-of-Care Diagnostics Devices And Equipment; Immunochemistry Diagnostic Devices And Equipment; Clinical Chemistry Diagnostics Devices And Equipment; Molecular Diagnostics Devices And Equipment; Microbiology Diagnostic Devices And Equipment; Hemostasis Diagnostic Devices And Equipment; Hematology Diagnostic Devices And Equipment; Immunohematology Diagnostic Devices And Equipment
  • 2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
  • 3) By Type of Expenditure: Public; Private
  • 4) By Product: Instruments/Equipment; Disposables
  • Subsegments:
  • 1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring; Pregnancy And Fertility Testing; Infectious Disease Testing; Cardiac Markers Testing; Coagulation Testing
  • 2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA); Western Blot; Immunofluorescence Assay; Chemiluminescence Immunoassay (CLIA)
  • 3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing; Cholesterol Testing; Liver Function Testing; Kidney Function Testing; Electrolyte Testing
  • 4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments; Next-Generation Sequencing (NGS) Instruments; Microarray Instruments; FISH (Fluorescence In Situ Hybridization) Devices
  • 5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems; Automated Identification Systems; Antimicrobial Susceptibility Testing Systems; Blood Culture Systems
  • 6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers; Thromboelastography Systems; Platelet Function Analyzers; Clotting Factor Analyzers
  • 7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers; Hemoglobin Testing Systems; Complete Blood Count (CBC) Devices; Blood Cell Counters
  • 8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems; Crossmatching Systems; Antibody Screening Systems; Blood Bank Analyzers
  • Companies Mentioned: Siemens Healthineers; F. Hoffmann-La Roche AG; Danaher Corporation; Abbott Laboratories Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Alere Inc.; Arkray Inc.; Becton, Dickinson and Company (BD); Bio-Rad Laboratories Inc.; bioMerieux SA; Grifols SA; Hologic Inc.; Werfen SA; Laboratory Corporation; Luminex Corporation; Ortho Clinical Diagnostics; PerkinElmer Inc.; Qiagen NV; Quest Diagnostics Inc.; QuidelOrtho Corporation; Sysmex Corporation; Illumina Inc.; Menarini Silicon Biosystems SPA; SpeeDx Pty. Ltd.; GENSPEED Biotech GmbH; Accelerate Diagnostics Inc.; Merck KGaA; Caris Life Sciences Inc.; Bio-Techne Corporation; Myriad Genetics Inc.; Genomic Health Inc.; Exact Sciences Crop.; Natera Inc.; Invitae Crop.; Veracyte Inc.
  • Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostics Market Characteristics

3. In Vitro Diagnostics Market Trends And Strategies

4. In Vitro Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In Vitro Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In Vitro Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In Vitro Diagnostics Market Growth Rate Analysis
  • 5.4. Global In Vitro Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In Vitro Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In Vitro Diagnostics Total Addressable Market (TAM)

6. In Vitro Diagnostics Market Segmentation

  • 6.1. Global In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Point-of-Care Diagnostics Devices And Equipment
  • Immunochemistry Diagnostic Devices And Equipment
  • Clinical Chemistry Diagnostics Devices And Equipment
  • Molecular Diagnostics Devices And Equipment
  • Microbiology Diagnostic Devices And Equipment
  • Hemostasis Diagnostic Devices And Equipment
  • Hematology Diagnostic Devices And Equipment
  • Immunohematology Diagnostic Devices And Equipment
  • 6.2. Global In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Public
  • Private
  • 6.3. Global In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments/Equipment
  • Disposables
  • 6.4. Global In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Other End Users
  • 6.5. Global In Vitro Diagnostics Market, Sub-Segmentation Of Point-of-Care Diagnostics Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Monitoring
  • Pregnancy And Fertility Testing
  • Infectious Disease Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • 6.6. Global In Vitro Diagnostics Market, Sub-Segmentation Of Immunochemistry Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Radioimmunoassay (RIA)
  • Western Blot
  • Immunofluorescence Assay
  • Chemiluminescence Immunoassay (CLIA)
  • 6.7. Global In Vitro Diagnostics Market, Sub-Segmentation Of Clinical Chemistry Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Testing
  • Cholesterol Testing
  • Liver Function Testing
  • Kidney Function Testing
  • Electrolyte Testing
  • 6.8. Global In Vitro Diagnostics Market, Sub-Segmentation Of Molecular Diagnostics Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR (Polymerase Chain Reaction) Instruments
  • Next-Generation Sequencing (NGS) Instruments
  • Microarray Instruments
  • FISH (Fluorescence In Situ Hybridization) Devices
  • 6.9. Global In Vitro Diagnostics Market, Sub-Segmentation Of Microbiology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microbial Culture Systems
  • Automated Identification Systems
  • Antimicrobial Susceptibility Testing Systems
  • Blood Culture Systems
  • 6.10. Global In Vitro Diagnostics Market, Sub-Segmentation Of Hemostasis Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coagulation Analyzers
  • Thromboelastography Systems
  • Platelet Function Analyzers
  • Clotting Factor Analyzers
  • 6.11. Global In Vitro Diagnostics Market, Sub-Segmentation Of Hematology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematology Analyzers
  • Hemoglobin Testing Systems
  • Complete Blood Count (CBC) Devices
  • Blood Cell Counters
  • 6.12. Global In Vitro Diagnostics Market, Sub-Segmentation Of Immunohematology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Typing Systems
  • Crossmatching Systems
  • Antibody Screening Systems
  • Blood Bank Analyzers

7. In Vitro Diagnostics Market Regional And Country Analysis

  • 7.1. Global In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Diagnostics Market

  • 8.1. Asia-Pacific In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Diagnostics Market

  • 9.1. China In Vitro Diagnostics Market Overview
  • 9.2. China In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Diagnostics Market

  • 10.1. India In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Diagnostics Market

  • 11.1. Japan In Vitro Diagnostics Market Overview
  • 11.2. Japan In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Diagnostics Market

  • 12.1. Australia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Diagnostics Market

  • 13.1. Indonesia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Diagnostics Market

  • 14.1. South Korea In Vitro Diagnostics Market Overview
  • 14.2. South Korea In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Bangladesh In Vitro Diagnostics Market

  • 15.1. Bangladesh In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.2. Bangladesh In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Bangladesh In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. Thailand In Vitro Diagnostics Market

  • 16.1. Thailand In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. Thailand In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. Thailand In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Vietnam In Vitro Diagnostics Market

  • 17.1. Vietnam In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Vietnam In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Vietnam In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. Malaysia In Vitro Diagnostics Market

  • 18.1. Malaysia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. Malaysia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. Malaysia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Singapore In Vitro Diagnostics Market

  • 19.1. Singapore In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Singapore In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Singapore In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Philippines In Vitro Diagnostics Market

  • 20.1. Philippines In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Philippines In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Philippines In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Hong Kong In Vitro Diagnostics Market

  • 21.1. Hong Kong In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.2. Hong Kong In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Hong Kong In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. New Zealand In Vitro Diagnostics Market

  • 22.1. New Zealand In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. New Zealand In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. New Zealand In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. Western Europe In Vitro Diagnostics Market

  • 23.1. Western Europe In Vitro Diagnostics Market Overview
  • 23.2. Western Europe In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. Western Europe In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. Western Europe In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. UK In Vitro Diagnostics Market

  • 24.1. UK In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.2. UK In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. UK In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Germany In Vitro Diagnostics Market

  • 25.1. Germany In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.2. Germany In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Germany In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. France In Vitro Diagnostics Market

  • 26.1. France In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.2. France In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. France In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Italy In Vitro Diagnostics Market

  • 27.1. Italy In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Italy In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Italy In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Spain In Vitro Diagnostics Market

  • 28.1. Spain In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.2. Spain In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Spain In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Spain In Vitro Diagnostics Market

  • 29.1. Spain In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.2. Spain In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Spain In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Austria In Vitro Diagnostics Market

  • 30.1. Austria In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 30.2. Austria In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 30.3. Austria In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

31. Belgium In Vitro Diagnostics Market

  • 31.1. Belgium In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 31.2. Belgium In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 31.3. Belgium In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

32. Denmark In Vitro Diagnostics Market

  • 32.1. Denmark In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 32.2. Denmark In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 32.3. Denmark In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

33. Finland In Vitro Diagnostics Market

  • 33.1. Finland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 33.2. Finland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 33.3. Finland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

34. Ireland In Vitro Diagnostics Market

  • 34.1. Ireland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 34.2. Ireland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 34.3. Ireland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

35. Netherlands In Vitro Diagnostics Market

  • 35.1. Netherlands In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 35.2. Netherlands In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 35.3. Netherlands In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

36. Norway In Vitro Diagnostics Market

  • 36.1. Norway In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 36.2. Norway In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 36.3. Norway In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

37. Portugal In Vitro Diagnostics Market

  • 37.1. Portugal In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 37.2. Portugal In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 37.3. Portugal In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

38. Sweden In Vitro Diagnostics Market

  • 38.1. Sweden In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 38.2. Sweden In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 38.3. Sweden In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

39. Switzerland In Vitro Diagnostics Market

  • 39.1. Switzerland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 39.2. Switzerland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 39.3. Switzerland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion40. Eastern Europe In Vitro Diagnostics Market
  • 40.1. Eastern Europe In Vitro Diagnostics Market Overview
  • 40.2. Eastern Europe In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 40.3. Eastern Europe In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 40.4. Eastern Europe In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

41. Russia In Vitro Diagnostics Market

  • 41.1. Russia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 41.2. Russia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 41.3. Russia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

42. Czech Republic In Vitro Diagnostics Market

  • 42.1. Czech Republic In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 42.2. Czech Republic In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 42.3. Czech Republic In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

43. Poland In Vitro Diagnostics Market

  • 43.1. Poland In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 43.2. Poland In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 43.3. Poland In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

44. Romania In Vitro Diagnostics Market

  • 44.1. Romania In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 44.2. Romania In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 44.3. Romania In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

45. Ukraine In Vitro Diagnostics Market

  • 45.1. Ukraine In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 45.2. Ukraine In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 45.3. Ukraine In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

46. North America In Vitro Diagnostics Market

  • 46.1. North America In Vitro Diagnostics Market Overview
  • 46.2. North America In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 46.3. North America In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 46.4. North America In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

47. USA In Vitro Diagnostics Market

  • 47.1. USA In Vitro Diagnostics Market Overview
  • 47.2. USA In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 47.3. USA In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 47.4. USA In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

48. Canada In Vitro Diagnostics Market

  • 48.1. Canada In Vitro Diagnostics Market Overview
  • 48.2. Canada In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 48.3. Canada In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 48.4. Canada In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 49.1. Mexico In Vitro Diagnostics Market Overview
  • 49.2. Mexico In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 49.3. Mexico In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 49.4. Mexico In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

50. South America In Vitro Diagnostics Market

  • 50.1. South America In Vitro Diagnostics Market Overview
  • 50.2. South America In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 50.3. South America In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 50.4. South America In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

51. Brazil In Vitro Diagnostics Market

  • 51.1. Brazil In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 51.2. Brazil In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 51.3. Brazil In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

52. Chile In Vitro Diagnostics Market

  • 52.1. Chile In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 52.2. Chile In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 52.3. Chile In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

53. Argentina In Vitro Diagnostics Market

  • 53.1. Argentina In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 53.2. Argentina In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 53.3. Argentina In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

54. Colombia In Vitro Diagnostics Market

  • 54.1. Colombia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 54.2. Colombia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 54.3. Colombia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

55. Peru In Vitro Diagnostics Market

  • 55.1. Peru In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 55.2. Peru In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 55.3. Peru In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

56. Middle East In Vitro Diagnostics Market

  • 56.1. Middle East In Vitro Diagnostics Market Overview
  • 56.2. Middle East In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 56.3. Middle East In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 56.4. Middle East In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

57. Saudi Arabia In Vitro Diagnostics Market

  • 57.1. Saudi Arabia In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 57.2. Saudi Arabia In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 57.3. Saudi Arabia In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

58. Israel In Vitro Diagnostics Market

  • 58.1. Israel In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 58.2. Israel In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 58.3. Israel In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

59. Iran In Vitro Diagnostics Market

  • 59.1. Iran In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 59.2. Iran In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 59.3. Iran In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

60. Turkey In Vitro Diagnostics Market

  • 60.1. Turkey In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 60.2. Turkey In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 60.3. Turkey In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

61. United Arab Emirates In Vitro Diagnostics Market

  • 61.1. United Arab Emirates In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 61.2. United Arab Emirates In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 61.3. United Arab Emirates In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

62. Africa In Vitro Diagnostics Market

  • 62.1. Africa In Vitro Diagnostics Market Overview
  • 62.2. Africa In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 62.3. Africa In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 62.4. Africa In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

63. Egypt In Vitro Diagnostics Market

  • 63.1. Egypt In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 63.2. Egypt In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 63.3. Egypt In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

64. Nigeria In Vitro Diagnostics Market

  • 64.1. Nigeria In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 64.2. Nigeria In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 64.3. Nigeria In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

65. South Africa In Vitro Diagnostics Market

  • 65.1. South Africa In Vitro Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 65.2. South Africa In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 65.3. South Africa In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

66. In Vitro Diagnostics Market Competitive Landscape And Company Profiles

  • 66.1. In Vitro Diagnostics Market Competitive Landscape
  • 66.2. In Vitro Diagnostics Market Company Profiles
    • 66.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 66.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

67. In Vitro Diagnostics Market Other Major And Innovative Companies

  • 67.1. Agilent Technologies Inc.
  • 67.2. Alere Inc.
  • 67.3. Arkray Inc.
  • 67.4. Becton, Dickinson and Company (BD)
  • 67.5. Bio-Rad Laboratories Inc.
  • 67.6. bioMerieux SA
  • 67.7. Grifols SA
  • 67.8. Hologic Inc.
  • 67.9. Werfen SA
  • 67.10. Laboratory Corporation
  • 67.11. Luminex Corporation
  • 67.12. Ortho Clinical Diagnostics
  • 67.13. PerkinElmer Inc.
  • 67.14. Qiagen NV
  • 67.15. Quest Diagnostics Inc.

68. Global In Vitro Diagnostics Market Competitive Benchmarking And Dashboard

69. Key Mergers And Acquisitions In The In Vitro Diagnostics Market

70. Recent Developments In The In Vitro Diagnostics Market

71. In Vitro Diagnostics Market High Potential Countries, Segments and Strategies

  • 71.1 In Vitro Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 71.2 In Vitro Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 71.3 In Vitro Diagnostics Market In 2029 - Growth Strategies
    • 71.3.1 Market Trend Based Strategies
    • 71.3.2 Competitor Strategies

72. Appendix

  • 72.1. Abbreviations
  • 72.2. Currencies
  • 72.3. Historic And Forecast Inflation Rates
  • 72.4. Research Inquiries
  • 72.5. The Business Research Company
  • 72.6. Copyright And Disclaimer